Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Emily Connell, Gwénaëlle Le Gall, Matthew G. Pontifex, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 119

Showing 1-25 of 119 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 196
Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis
Stefanie Grabrucker, Moira Marizzoni, Edina Silajdžić, et al.
Brain (2023) Vol. 146, Iss. 12, pp. 4916-4934
Open Access | Times Cited: 107
Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis
Jody Rusch, Brian T. Layden, Lara R. Dugas
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 97
Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health
Zhijie Wan, Jianheng Zheng, Zhigang Zhu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 90
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Dong-oh Seo, David M. Holtzman
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 86-94
Open Access | Times Cited: 72
The changing metabolic landscape of bile acids – keys to metabolism and immune regulation
Ipsita Mohanty, Celeste Allaband, Helena Mannochio-Russo, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 7, pp. 493-516
Closed Access | Times Cited: 50
Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial
Mary Ní Lochlainn, Ruth C. E. Bowyer, Janne Marie Moll, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Assessing the contribution of the chemical exposome to neurodegenerative disease
Sophie Lefèvre‐Arbogast, Jade Chaker, Fabien Mercier, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 5, pp. 812-821
Closed Access | Times Cited: 23
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Yuanyuan Ma, Xin Li, Jin‐Tai Yu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Overlooked cases of mild cognitive impairment: Implications to early Alzheimer’s disease
Maamoon Mian, Jihane Tahiri, Ryan Eldin, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102335-102335
Closed Access | Times Cited: 15
Precision Psychobiotics for Gut–Brain Axis Health: Advancing the Discovery Pipelines to Deliver Mechanistic Pathways and Proven Health Efficacy
Rebecca F. Slykerman, Naomi Davies, Klára Vlčková, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
The gut microbiota‐astrocyte axis: Implications for type 2 diabetic cognitive dysfunction
Zi-han Li, Yayi Jiang, Caiyi Long, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. S1, pp. 59-73
Open Access | Times Cited: 27
The importance of the gut microbiome and its signals for a healthy nervous system and the multifaceted mechanisms of neuropsychiatric disorders
Lydia Riehl, Johannes Fürst, Michaela Kress, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 13
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Yaxi Luo, Ling-Ling Yang, Xiu‐Qing Yao
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 13
The Brain–Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review
Eugenio Caradonna, Raffaello Nemni, Angelo Bifone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4130-4130
Open Access | Times Cited: 12
Gut microbiome predicts cognitive function and depressive symptoms in late life
Antonija Kolobaric, Carmen Andreescu, Eldin Jašarević, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 10, pp. 3064-3075
Open Access | Times Cited: 11
Dietary (Poly)phenols and the Gut–Brain Axis in Ageing
Léonie Láng, Simon McArthur, Alpár S. Lázár, et al.
Nutrients (2024) Vol. 16, Iss. 10, pp. 1500-1500
Open Access | Times Cited: 11
Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients?
Begoña Talavera Andújar, Arnaud Mary, Carmen Venegas, et al.
Environmental Science & Technology (2024)
Open Access | Times Cited: 9
Do microbes play a role in Alzheimer's disease?
Zoë Williams, Léonie Láng, Sarah Nicolas, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 9
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Alejandro Borrego-Ruiz, Juan J. Borrego
Experimental Gerontology (2024) Vol. 194, pp. 112497-112497
Open Access | Times Cited: 9
Gut microbiota–astrocyte axis: new insights into age-related cognitive decline
Lan Zhang, Jingge Wei, Xilei Liu, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 4, pp. 990-1008
Open Access | Times Cited: 9
Quinoline–sulfonamides as a multi-targeting neurotherapeutic for cognitive decline:in vitro,in silicostudies and ADME evaluation of monoamine oxidases and cholinesterases inhibitors
Saquib Jalil, Zahid Hussain, Syed Mobashir Ali Abid, et al.
RSC Advances (2024) Vol. 14, Iss. 13, pp. 8905-8920
Open Access | Times Cited: 8
The Probiotic Lactobacillus reuteri Preferentially Synthesizes Kynurenic Acid from Kynurenine
Robert Schwarcz, A Y Foo, Korrapati V. Sathyasaikumar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3679-3679
Open Access | Times Cited: 8
A detection model for cognitive dysfunction based on volatile organic compounds from a large Chinese community cohort
Bin Jiao, Sizhe Zhang, Yuzhang Bei, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4852-4862
Open Access | Times Cited: 16
Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia
Amber Yaqub, Dina Vojinović, Meike W. Vernooij, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top